Previous 10 | Next 10 |
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, has expanded its contract development and manufacturing organization (CDMO) capabilities at TriLink BioTech...
The following slide deck was published by Maravai LifeSciences Holdings, Inc. in conjunction with this event. For further details see: Maravai Lifesciences Holdings (MRVI) Investor Presentation - Slideshow
Best Biotech Stocks To Buy [Or Sell] In The Stock Market Today Biotech stocks are on many investors’ radar these days and for good reason. Given how these stocks are usually more sheltered from global events like economic uncertainty and a pandemic, it starts to be clear ...
Image source: The Motley Fool. Maravai LifeSciences Holdings Inc. (NASDAQ: MRVI) Q4 2020 Earnings Call Mar 02, 2021 , 5:00 p.m. ET Continue reading For further details see: Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) Q4 202...
Ovid Therapeutics (OVID) +73% after soticlestat deal with Takeda.KemPharm (KMPH) +69% on FDA approval of ADHD drug.Ocugen, Inc. (OCGN) +39% on Indian partner’s COVID-19 vaccine efficacy data.Asensus Surgical (TRXC) +33% on FDA clearance for Senhance Surgical System....
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2020 Earnings Conference Call March 02, 2021, 05:00 PM ET Company Participants Debra Hart - Senior Director, IR Carl Hull - Partner, Co-Founder, CEO Kevin Herde - VP, CFO Eric Tardif - Partner, Co-Founder, President Conference Call Participants Te...
Maravai LifeSciences Holdings (MRVI): Q4 GAAP EPS of $0.13 beats by $0.04.Revenue of $98.4M (+173.6% Y/Y) beats by $47.42M.Press Release For further details see: Maravai LifeSciences Holdings EPS beats by $0.04, beats on revenue
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and the full year ended Dece...
[[AMBA]], [[BGS]], [[BOX]], [[DAR]], [[FUBO]], [[GO]], [[HPE]], [[JWN]], [[MRVI]], [[ROST]], [[URBN]], [[VEEV]]For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings after Tuesday's close
SAN DIEGO, March 01, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in two upcoming virtual investor conferences. On March 3, 2021, ...
News, Short Squeeze, Breakout and More Instantly...
Maravai LifeSciences Holdings Inc. Company Name:
MRVI Stock Symbol:
NASDAQ Market:
Maravai LifeSciences Holdings Inc. Website:
2024-07-25 20:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
SAN DIEGO, July 10, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2024 financial and operating results after the market closes on...
- Highlights progress across four priority areas and commitment to environmentally and socially responsible growth. - Conducted first stakeholder assessment to identify and prioritize ESG issues that are most important for Maravai and our stakeholders. - Increased the sc...